- The PRODIGY Trial, a randomized comparison of 6 versus 24 months clopidogrel therapy in all comer patients undergoing percutaneous coronary intervention (Marco VALGIMIGLI,Ferrara)
- Bern-Rottedarm Cohort Study - Newer generation everolimus-eluting stents eliminate the risk of very late stent thrombosis compared with early generation sirolimus-eluting and paclitaxel-eluting stents (Lorenz RÄBER, Bern)
- ESC Guidelines - Acute coronary syndrome and non ST-elevation (Christian HAMM, Bad Nauheim and Jean-Pierre BASSAND, Besançon)
- First results from FRANCE II, the French registry aortic national corevalve and Edwards registry II (Martine GILARD, Brest)

свернуть